Epinephrine Transdermal Patch 0.25mg from Canada
Sustained-release epinephrine transdermal patch delivering 0.25mg over 24 hours for chronic allergy management. Put up in measured doses as retail transdermal system. Classifies under HTS 3004.39.0020 for epinephrine content.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Adhesive skin irritation testing reports mandatory
• Controlled release kinetics data prevents reclassification as simple patch
• Shelf-life extension studies for matrix stability required